Research progress of therapeutic vaccines for treating chronic hepatitis B.

about

Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.

P2860

Q47561286-92BC612E-4A93-44BA-8CBC-CE6397E082F9

P2860

Research progress of therapeutic vaccines for treating chronic hepatitis B.

Item

http://www.wikidata.org/entity/Q39101021

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@en

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@nl

type

Item

label

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@en

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@nl

prefLabel

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@en

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@nl

P1476

Research progress of therapeutic vaccines for treating chronic hepatitis B.

@en

P2093

Fengchun Qi

http://www.w3.org/2001/XMLSchema#string

Jia Dou

http://www.w3.org/2001/XMLSchema#string

Jianqiang Li

http://www.w3.org/2001/XMLSchema#string

Jun Ge

http://www.w3.org/2001/XMLSchema#string

Mengru Bao

http://www.w3.org/2001/XMLSchema#string

Sulin Ren

http://www.w3.org/2001/XMLSchema#string

Tong Zhou

http://www.w3.org/2001/XMLSchema#string

Xiuying Pu

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Epidemiology and Prevention of Hepatitis B Virus Infection

Immunology of hepatitis B virus and hepatitis C virus infection

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

Immune effectors required for hepatitis B virus clearance

Principles of adoptive T cell cancer therapy.

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

Adenoviruses as vaccine vectors.

Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.

P304

986-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1276125

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28118084

http://www.w3.org/2001/XMLSchema#string

P932

5443370

http://www.w3.org/2001/XMLSchema#string

Research progress of therapeutic vaccines for treating chronic hepatitis B.

about

P2860

P2860

Research progress of therapeutic vaccines for treating chronic hepatitis B.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932